모아바이오는 Biological 생산기업인 Proteogenix의 한국 독점 대리점 입니다. 많은 문의 부탁드립니다!
Proteogenix Best 제품! Endotoxin Free등 Customizing 가능! Bulk 주문 가능!
Proteogenix의 바이오시밀러 제품 리스트를 확인 해보세요!
No.
|
Catalog#
|
Product name
|
Host Species
|
1
|
PX-TA1576-100UG
|
Amivantamab Biosimilar – Anti-EGFR, ME, RCCP2 mAb – Research Grade
|
Homo sapiens
|
2
|
PX-TA1492-100UG
|
Bemarituzumab Biosimilar – Anti-FGFR2 mAb – Research Grade
|
Humanized
|
3
|
PX-TA1495-100UG
|
Narsoplimab Biosimilar – Anti-MASP2 mAb – Research Grade
|
Homo sapiens
|
4
|
PX-TA1033-100UG
|
Cilgavimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade
|
Humanized
|
5
|
PX-TA1637-100UG
|
Sotrovimab Biosimilar – Anti-Spike glycoprotein mAb – Research Grade
|
-
|
6
|
PX-TA1032-100UG
|
Tixagevimab Biosimilar – Anti-Covid Spike RBD mAb – Research Grade
|
Humanized
|
7
|
PX-TA1501-100UG
|
Faricimab Biosimilar – Anti-ANGPT2, VEGFA mAb – Research Grade
|
Humanized
|
8
|
PX-TA1475-100UG
|
Gatipotuzumab Biosimilar – Anti-MUC1, CD227 mAb – Research Grade
|
Humanized
|
9
|
PX-TA1626-100UG
|
Anti-LGR4 Biosimilar – Anti-LGR4 mAb – Research Grade
|
-
|
10
|
PX-TA1624-100UG
|
Anti-CLDN18.2 Biosimilar – Anti-Claudin18.2 mAb – Research Grade
|
-
|
11
|
PX-TA1625-100UG
|
Anti-CD28 Biosimilar – Anti-CD28(Tp44) mAb – Research Grade
|
-
|
12
|
PX-TA1623-100UG
|
Anti-Zika Virus Envelope Protein Biosimilar – Anti-Zika Virus mAb – Research Grade
|
-
|
13
|
PX-TA1622-100UG
|
Anti-Envelope protein E Biosimilar – Anti-Dengue virus mAb – Research Grade
|
-
|
14
|
PX-TA1333-100UG
|
Enfortumab Biosimilar – Anti-PVRL4 mAb – Research Grade
|
-
|
15
|
PX-TA1329-100UG
|
Vantictumab Biosimilar – Anti-FZD mAb – Research Grade
|
Homo sapiens
|
16
|
PX-TA1330-100UG
|
Anetumab Biosimilar – Anti-MSLN mAb – Research Grade
|
Homo sapiens
|
17
|
PX-TA1331-100UG
|
Margetuximab Biosimilar – Anti-ERBB2, EGFR2, CD340 mAb – Research Grade
|
Chimeric
|
18
|
PX-TA1332-100UG
|
Anifrolumab Biosimilar – Anti-IFNAR1 mAb – Research Grade
|
Homo sapiens
|
19
|
PX-TA1339-100UG
|
Ulocuplumab Biosimilar – Anti-CXCR4, CD184 mAb – Research Grade
|
Homo sapiens
|
20
|
PX-TA1334-100UG
|
Lifastuzumab Biosimilar – Anti-SLC34A2 mAb – Research Grade
|
Humanized
|
21
|
PX-TA1447-100UG
|
Sacituzumab Biosimilar – Anti-TACSTD2 mAb – Research Grade
|
Humanized
|
22
|
PX-TA1703-100UG
|
Pimurutamab Biosimilar – Anti-EGFR mAb – Research Grade
|
Humanized
|
23
|
PX-TA1019-100UG
|
Cetuximab Biosimilar – Anti-hEGFR mAb – Research Grade
|
Mouse/Human
|
24
|
PX-TA1277-100UG
|
Indatuximab Biosimilar – Anti-SDC1, CD138 mAb – Research Grade
|
Chimeric
|
25
|
PX-TA1276-100UG
|
Vatelizumab Biosimilar – Anti-ITGA2 mAb – Research Grade
|
Humanized
|
26
|
PX-TA1361-100UG
|
Firivumab Biosimilar – Anti-hemagglutinin HA mAb – Research Grade
|
Homo sapiens
|
27
|
PX-TA1190-100UG
|
Urtoxazumab Biosimilar – Anti-Stx-2, SLT-II mAb – Research Grade
|
Humanized
|
28
|
PX-TA1018-100UG
|
Denosumab Biosimilar – Anti-RANKL mAb – Research Grade
|
Human
|
29
|
PX-TA1702-100UG
|
Pimivalimab Biosimilar – Anti-PDCD1 mAb – Research Grade
|
Homo sapiens
|
30
|
PX-TA1446-100UG
|
Rosmantuzumab Biosimilar – Anti-RSPO3 mAb – Research Grade
|
Humanized
|
31
|
PX-TA1104-100UG
|
Abciximab Biosimilar – Anti-ITGA2B_ITGB3 mAb – Research Grade
|
Chimeric
|
32
|
PX-TA1789-100
|
Trinbelimab Biosimilar – Anti-Rhesus D antigen mAb – Research Grade
|
Homo sapiens
|
33
|
PX-TA1531-100UG
|
Orilanolimab Biosimilar – Anti-FCGRT mAb – Research Grade
|
Chimeric
|
34
|
PX-TA1876-100
|
Peresolimab Biosimilar – Anti-PDCD1 mAb – Research Grade
|
-
|
35
|
PX-TA1874-100
|
Pabinafusp Biosimilar – Anti-TFRC mAb – Research Grade
|
-
|
36
|
PX-TA1616-100UG
|
Veltuzumab Biosimilar – Anti- CD20 receptors mAb – Research Grade
|
Humanized
|
37
|
PX-TA1360-100UG
|
Lenzilumab Biosimilar – Anti-CSF2 mAb – Research Grade
|
Homo sapiens
|
38
|
PX-TA1275-100UG
|
Tabalumab Biosimilar – Anti-TNFSF13B, CD257 mAb – Research Grade
|
Homo sapiens
|
39
|
PX-TA1017-100UG
|
Dulaglutide Biosimilar – Anti-Glucagon-like peptide-1 receptor agonist mAb – Research Grade
|
Human
|
40
|
PX-TA1701-100UG
|
Pelgifatamab Biosimilar – Anti-FOLH1 mAb – Research Grade
|
Homo sapiens
|
41
|
PX-TA1618-100UG
|
9-77 Biosimilar – Anti-IL-8 mAb – Research Grade
|
-
|
42
|
PX-TA1020-100UG
|
Abatacept Biosimilar – Anti-CTLA-4 extracellular domain linked to IgG1 Fc mAb – Research Grade
|
Human
|
43
|
PX-TA1192-100UG
|
Elsilimomab Biosimilar – Anti-IL6 mAb – Research Grade
|
Mus musculus
|
44
|
PX-TA1449-100UG
|
Brazikumab Biosimilar – Anti-IL23A mAb – Research Grade
|
Homo sapiens
|
45
|
PX-TA1706-100UG
|
Pucotenlimab Biosimilar – Anti-PDCD1 mAb – Research Grade
|
Chimeric
|
46
|
PX-TA1450-100UG
|
Emapalumab Biosimilar – Anti-IFNG mAb – Research Grade
|
Homo sapiens
|
47
|
PX-TA1108-100UG
|
cBR96 Biosimilar – Anti-Lewis Y mAb – Research Grade
|
-
|
48
|
PX-TA1793-100UG
|
Teropavimab Biosimilar – Anti-Surface protein gp120 mAb – Research Grade
|
Humanized
|
49
|
PX-TA1535-100UG
|
Rolinsatamab Biosimilar – Anti-PRLR mAb – Research Grade
|
Chimeric
|
50
|
PX-TA1194-100UG
|
Aselizumab Biosimilar – Anti-SELL, CD62L mAb – Research Grade
|
Humanized
|
51
|
PX-TA1877-100UG
|
Posdinemab Biosimilar – Anti-MAPT mAb – Research Grade
|
-
|
52
|
PX-TA1620-100UG
|
Ibritumomab Biosimilar – Anti-MS4A1(CD20,MS4A-1) mAb – Research Grade
|
-
|
53
|
PX-TA1364-100UG
|
Lacutamab Biosimilar – Anti-KIR3DL2 mAb – Research Grade
|
Humanized
|
54
|
PX-TA1279-100UG
|
Inclacumab Biosimilar – Anti-SELP mAb – Research Grade
|
Homo sapiens
|
55
|
PX-TA1021-100UG
|
Ipilimumab Biosimilar – Anti-CTLA-4 mAb – Research Grade
|
Human
|
56
|
PX-TA1705-100UG
|
Plonmarlimab Biosimilar – Anti-CSF2 mAb – Research Grade
|
Humanized
|
57
|
PX-TA1107-100UG
|
Bavituximab Biosimilar – Anti-Phosphatidylserine mAb – Research Grade
|
Chimeric
|
58
|
PX-TA1533-100UG
|
Prolgolimab Biosimilar – Anti-PDCD1, PD1, CD279 mAb – Research Grade
|
Homo sapiens
|
59
|
PX-TA1792-100UG
|
Eblasakimab Biosimilar – Anti-IL13R mAb – Research Grade
|
Homo sapiens
|
60
|
PX-TA1534-100UG
|
Osocimab Biosimilar – Anti-F11 mAb – Research Grade
|
Homo sapiens
|
61
|
PX-TA1193-100UG
|
Pritumumab Biosimilar – Anti-VIM mAb – Research Grade
|
Homo sapiens
|
62
|
PX-TA1878-100UG
|
Plutavimab Biosimilar – Anti-SARS-CoV-2 Spike RBD mAb – Research Grade
|
-
|
63
|
PX-TA1619-100UG
|
Meplazumab Biosimilar – Anti-CD147 mAb – Research Grade
|
-
|
64
|
PX-TA1363-100UG
|
Obexelimab Biosimilar – Anti-CD19 mAb – Research Grade
|
Chimeric
|
65
|
PX-TA1278-100UG
|
Caplacizumab Biosimilar – Anti-VWF A1 domain mAb – Research Grade
|
Humanized
|
66
|
PX-TA1103-100UG
|
cT84.66 Biosimilar – Anti-CEACAM5, CD66e mAb – Research Grade
|
-
|
67
|
PX-TA1704-100UG
|
Ponsegromab Biosimilar – Anti-GDF15 mAb – Research Grade
|
Humanized
|
68
|
PX-TA1448-100UG
|
Ranevetmab Biosimilar – Anti-NGF, NGFB mAb – Research Grade
|
Caninized
|
69
|
PX-TA1106-100UG
|
Basiliximab Biosimilar – Anti-IL2RA, CD25 mAb – Research Grade
|
Chimeric
|
70
|
PX-TA1791-100UG
|
Bafisontamab Biosimilar – Anti-ERBB1 mAb – Research Grade
|
Humanized
|
71
|
PX-TA1445-100UG
|
Camrelizumab Biosimilar – Anti-PDCD1, PD-1, CD279 mAb – Research Grade
|
Humanized
|
72
|
PX-TA1016-100UG
|
Aflibercept Biosimilar – Anti-VEGF mAb – Research Grade
|
Human
|
73
|
PX-TA1788-100UG
|
Manfidokimab Biosimilar – Anti-IL-4 receptor subunit alpha mAb – Research Grade
|
Humanized
|
74
|
PX-TA1185-100UG
|
Inotuzumab Biosimilar – Anti-CD22 mAb – Research Grade
|
Humanized
|
75
|
PX-TA1785-100UG
|
Quisovalimab Biosimilar – Anti-CD258 mAb – Research Grade
|
Homo sapiens
|
76
|
PX-TA1527-100UG
|
Frovocimab Biosimilar – Anti-PCSK9 mAb – Research Grade
|
Humanized
|
77
|
PX-TA1186-100UG
|
Raxibacumab Biosimilar – Anti-Anthrax protective antigen mAb – Research Grade
|
Homo sapiens
|
78
|
PX-TA1870-100UG
|
Ogalvibart Biosimilar – Anti-SARS-CoV-2 Spike RBD mAb – Research Grade
|
-
|
79
|
PX-TA1612-100UG
|
Zelminemab Biosimilar – Anti-ADCYAP1R1 mAb – Research Grade
|
-
|
80
|
PX-TA1356-100UG
|
Emactuzumab Biosimilar – Anti-CSF1R, CD115 mAb – Research Grade
|
Humanized
|
81
|
PX-TA1271-100UG
|
Narnatumab Biosimilar – Anti-MST1R, CD136 mAb – Research Grade
|
Homo sapiens
|
82
|
PX-TA1013-100UG
|
Zolbetuximab Biosimilar – Anti-CLDN18.2 mAb – Research Grade
|
Human
|
83
|
PX-TA1697-100UG
|
Opucolimab Biosimilar – Anti-PDL1 mAb – Research Grade
|
Humanized
|
84
|
PX-TA1441-100UG
|
Dezamizumab Biosimilar – Anti-APCS mAb – Research Grade
|
Humanized
|
85
|
PX-TA1099-100UG
|
Sulesomab Biosimilar – Anti-NCA-90 mAb – Research Grade
|
Mus musculus
|
86
|
PX-TA1784-100UG
|
Rocatinlimab Biosimilar – Anti-CD134 mAb – Research Grade
|
Homo sapiens
|
87
|
PX-TA1869-100UG
|
Nepuvibart Biosimilar – Anti-SARS-CoV-2 Spike RBD mAb – Research Grade
|
-
|
88
|
PX-TA1442-100UG
|
Telisotuzumab Biosimilar – Anti-MET, RCCP2 mAb – Research Grade
|
Humanized
|
89
|
PX-TA1611-100UG
|
Zagotenemab Biosimilar – Anti-MAPT mAb – Research Grade
|
Humanized
|
90
|
PX-TA1355-100UG
|
Vanucizumab Biosimilar – Anti-ANGPT2, VEGFA, mAb – Research Grade
|
Humanized
|
91
|
PX-TA1270-100UG
|
Ficlatuzumab Biosimilar – Anti-HGF mAb – Research Grade
|
Humanized
|
92
|
PX-TA1012-100UG
|
Utomilumab Biosimilar – Anti-Human TNFRSF9 mAb – Research Grade
|
Human
|
93
|
PX-TA1696-100UG
|
Ongericimab Biosimilar – Anti-PCSK9 mAb – Research Grade
|
Humanized
|
94
|
PX-TA1440-100UG
|
Lutikizumab Biosimilar – Anti-IL1A , IL1B mAb – Research Grade
|
Humanized
|
95
|
PX-TA1098-100UG
|
Satumomab Biosimilar – Anti-TAG-72 mAb – Research Grade
|
Mus musculus
|
96
|
PX-TA1783-100UG
|
Ecleralimab Biosimilar – Anti-TSLP mAb – Research Grade
|
Humanized
|
97
|
PX-TA1525-100UG
|
Dilpacimab Biosimilar – Anti-DLL4, VEGFA mAb – Research Grade
|
Humanized
|
98
|
PX-TA1184-100UG
|
Besilesomab Biosimilar – Anti-CEACAM8, CD66b mAb – Research Grade
|
Mus musculus
|
99
|
PX-TA1868-100UG
|
Naptumomab Biosimilar – Anti-TPBG mAb – Research Grade
|
-
|
100
|
PX-TA1610-100UG
|
Vibostolimab Biosimilar – Anti-TIGIT, VSIG9, VSTM3 mAb – Research Grade
|
-
|
101
|
PX-TA1100-100UG
|
Clostridium perfringens Biosimilar – Anti-CSPG4, HMW-MAA, CD3E, ERBB2, toxin mAb – Research Grade
|
-
|
102
|
PX-TA1698-100UG
|
Pacanalotamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
|
Humanized
|
103
|
PX-TA1530-100UG
|
Nirsevimab Biosimilar – Anti-RSV mAb – Research Grade
|
Humanized
|
104
|
PX-TA1872-100UG
|
Osemitamab Biosimilar – Anti-CLDN18 mAb – Research Grade
|
-
|
105
|
PX-TA1189-100UG
|
Libivirumab Biosimilar – Anti-HBV, HBsAg mAb – Research Grade
|
Homo sapiens
|
106
|
PX-TA1873-100UG
|
Ozuriftamab Biosimilar – Anti-ROR2 mAb – Research Grade
|
-
|
107
|
PX-TA1615-100UG
|
Tavolimab Biosimilar – Anti-TNF- SF4 receptor I mAb – Research Grade
|
Homo sapiens
|
108
|
PX-TA1359-100UG
|
Imalumab Biosimilar – Anti-MIF mAb – Research Grade
|
Homo sapiens
|
109
|
PX-TA1274-100UG
|
Sirukumab Biosimilar – Anti-IL6 mAb – Research Grade
|
Homo sapiens
|
110
|
PX-TA1280-100UG
|
Flanvotumab Biosimilar – Anti-TYRP1 mAb – Research Grade
|
Homo sapiens
|
111
|
PX-TA1700-100UG
|
Pavurutamab Biosimilar – Anti-TNFRSF17;CD3E mAb – Research Grade
|
Humanized
|
112
|
PX-TA1444-100UG
|
Vunakizumab Biosimilar – Anti-IL17A mAb – Research Grade
|
Humanized
|
113
|
PX-TA1102-100UG
|
Homo sapiens Biosimilar – Anti-DNA, histone(H1) complex mAb – Research Grade
|
Chimeric
|
114
|
PX-TA1787-100UG
|
Ligufalimab Biosimilar – Anti-CD47 mAb – Research Grade
|
Chimeric
|
115
|
PX-TA1529-100UG
|
Marstacimab Biosimilar – Anti-TFPI mAb – Research Grade
|
Homo sapiens
|
116
|
PX-TA1188-100UG
|
Exbivirumab Biosimilar – Anti-HBV/HBsAg mAb – Research Grade
|
Homo sapiens
|
117
|
PX-TA1614-100UG
|
Basilixumab Biosimilar – Anti-IL-2 receptor mAb – Research Grade
|
-
|
118
|
PX-TA1014-100UG
|
PSMA Biosimilar – Anti-PSMA mAb – Research Grade
|
-
|
119
|
PX-TA1358-100UG
|
Begelomab Biosimilar – Anti-DPP4, TP103, CD26 mAb – Research Grade
|
Mus musculus
|
|
|
* 이 외에도 500여가지의 다양한 Biosimilar 제품들이 있습니다! - 링크 확인!
|
|
Proteogenix의 SARS 관련 모든 제품들을 확인 해보세요!
No.
|
Catalog#
|
Product name
|
Host Species
|
1
|
PX-COV-P007-10
|
2′-O-methyltransferase
|
Escherichia coli (E.coli)
|
2
|
PX-COV-P003-10
|
3CLpro protein; 3C-Like-proteinase
|
Escherichia coli (E.coli)
|
3
|
PX-COV-P048-10
|
ACE2 protein – Soluble ectodomain of human ACE-2 (aa 1-740)
|
Mammalian cells
|
4
|
PX-COV-P014-10
|
CoV-S [819-919]
|
Escherichia coli (E. coli)
|
5
|
PX-COV-P012
|
CoV-S[1047-1210]
|
Escherichia coli (E. coli)
|
6
|
PX-COV-P011-10
|
CoV-S[679-833]
|
Escherichia coli (E. coli)
|
7
|
PX-COV-P008-10
|
Growth factor-like peptide
|
Escherichia coli (E.coli)
|
8
|
PX-COV-P073-10
|
Human ADAM9 Recombinant Protein
|
Escherichia coli (E. coli)
|
9
|
PX-COV-P057
|
Human AXL protein
|
Mammalian cells
|
10
|
PX-COV-P025-10
|
SARS-CoV-2 Membrane protein(M protein)
|
Escherichia coli (E. coli)
|
11
|
PX-COV-P028-10
|
Non-structural protein 1(NSP1)
|
Escherichia coli (E. coli)
|
12
|
PX-COV-P031-10
|
Non-structural protein 13(NSP13)
|
Escherichia coli (E. coli)
|
13
|
PX-COV-P030-10
|
Nidoviral RNA uridylate-specific endoribonuclease(NSP15)
|
Escherichia coli (E. coli)
|
14
|
PX-COV-P029-10
|
Non-structural protein 2(NSP2)
|
Escherichia coli (E. coli)
|
15
|
PX-COV-P005-10
|
NSP3, PL2pro domain
|
Escherichia coli (E. coli)
|
16
|
PX-COV-P018-10
|
Nonstructural protein 9 (nsp9)
|
Escherichia coli (E. coli)
|
17
|
PX-COV-P010-10
|
Nucleoprotein
|
Escherichia coli (E. coli)
|
18
|
PX-COV-P004-10
|
Peptidase C16 domain of PL-Pro (746-1064); nsp3
|
Escherichia coli (E. coli)
|
19
|
PX-COV-P046-10
|
RBD Domain
|
Mammalian cells
|
20
|
PX-COV-P047-10
|
RBD-Fc
|
Mammalian cells
|
21
|
PX-COV-P006-10
|
RdRp catalytic domain of RNA-directed RNA polymerase
|
Escherichia coli (E. coli)
|
22
|
PX-COV-P060-10
|
Recombinant Human Retinoic acid-inducible gene I protein
|
Escherichia coli (E. coli)
|
23
|
PX-COV-P066-10
|
SARS-CoV-2 Accessory Protein 10
|
Escherichia coli (E.coli)
|
24
|
PX-COV-P063
|
SARS-CoV-2 Accessory Protein 3a
|
Escherichia coli (E. coli)
|
25
|
PX-COV-P067
|
SARS-CoV-2 Accessory Protein 3b, N-Sumo Tag
|
Escherichia coli (E. coli)
|
26
|
PX-COV-P064-10
|
SARS-CoV-2 Accessory Protein 6
|
Escherichia coli (E. coli)
|
27
|
PX-COV-P065-10
|
SARS-CoV-2 Accessory Protein 9b
|
Escherichia coli (E. coli)
|
28
|
PX-COV-P068-10
|
SARS-CoV-2 RBD Domain produced in Yeast, C-His Tag
|
Yeast
|
29
|
PX-COV-P074-10
|
SARS-CoV-2 RBD of Spike protein– lineage B.1.1.529 – Omicron Variant
|
Mammalian cells
|
30
|
PX-COV-P075-10
|
SARS-CoV-2 RBD of Spike protein– lineage B.1.1.529 – Omicron Variant (Q493R)-Fc tag
|
Mammalian cells
|
31
|
PX-COV-P077
|
SARS-CoV-2 RBD of Spike protein– XE – Omicron Variant
|
Mammalian cells
|
32
|
PX-COV-P076-10
|
SARS-CoV-2 RBD of Spike protein–BA.2 lineage B.1.1.529.2 – Omicron Variant
|
Mammalian cells
|
33
|
PX-COV-P078-10
|
SARS-CoV-2 RBD of Spike protein–BA.4 lineage B.1.1.529.4 – Omicron Variant
|
Mammalian cells
|
34
|
PX-COV-P079-10
|
SARS-CoV-2 RBD of Spike protein–BA.5 lineage B.1.1.529.5 – Omicron Variant
|
Mammalian cells
|
35
|
PX-COV-P059-10
|
SARS-CoV-2 RBD of Spike protein, E484Q, L452R – lineage B.1.617 – Indian Kappa Variant
|
Mammalian cells
|
36
|
PX-COV-P055-10
|
SARS-CoV-2 RBD of Spike protein, CAL.20C, L452R – lineage B.1.429 – CAL Epsilon Variant
|
Mammalian cells
|
37
|
PX-COV-P071-10
|
SARS-CoV-2 RBD of Spike protein, E484D
|
Mammalian cells
|
38
|
PX-COV-P056-10
|
SARS-CoV-2 RBD of Spike protein, E484K
|
Mammalian cells
|
39
|
PX-COV-P053-10
|
SARS-CoV-2 RBD of Spike protein, K417N, E484K, N501Y – B.1.351 lineage – SA Beta Variant
|
Mammalian cells
|
40
|
PX-COV-P062-10
|
SARS-CoV-2 RBD of Spike protein, K417N, T478K, L452R– lineage B.1.617.2.1 – Indian Delta Plus Variant
|
Mammalian cells
|
41
|
PX-COV-P054-10
|
SARS-CoV-2 RBD of Spike protein, K417T, E484K, N501Y – lineage B.1.1.28.1 – BR Gamma Variant
|
Mammalian cells
|
42
|
PX-COV-P069-10
|
SARS-CoV-2 RBD of Spike protein, L452Q, F490S– lineage C.37 – Peru Lambda Variant
|
Mammalian cells
|
43
|
PX-COV-P061-10
|
SARS-CoV-2 RBD of Spike protein, L452R, T478K – lineage B.1.617.2 – Indian Delta Variant
|
Mammalian cells
|
44
|
PX-COV-P052-10
|
SARS-CoV-2 RBD of Spike protein, N501Y – B 1.1.7 lineage – UK Alpha Variant
|
Mammalian cells
|
45
|
PX-COV-P070-10
|
SARS-CoV-2 RBD of Spike protein, R346K, E484K, N501Y, D614G, P681H– lineage B.1.621 – Colombia Mu Variant
|
Mammalian cells
|
46
|
PX-COV-P058-100
|
SARS-CoV-2 RBD of Spike protein, S477N – lineage B.1.526 – NY Iota Variant
|
Mammalian cells
|
47
|
PX-COV-P072-10
|
SARS-CoV-2 RBD of Spike protein, Y449H, E484K, N501Y – C.1.2 lineage – South Africa
|
Mammalian cells
|
48
|
PX-COV-P049-10
|
SARS-CoV-2 Spike full length (trimer form), D614
|
Mammalian cells
|
49
|
PX-COV-P051-10
|
SARS-CoV-2 Spike full length, G614
|
Mammalian cells
|
50
|
PX-COV-P002-10
|
Spike Protein S1
|
Mammalian cells
|
51
|
PX-COV-P045-10
|
Spike protein S2
|
Escherichia coli (E. coli)
|
52
|
PX-COV-P044-10
|
TMPRSS2
|
Escherichia coli (E. coli)
|
Proteogenix의 Monkeypox(원숭이 두창)관련 제품 리스트
|
MONKEY POX 관련 제품 |
Proteogenix |
|
No. |
Catalog# |
Product name |
Host Species |
1 |
PX-P6054-100UG |
Recombinant Monkeypox virus/MPXV A27L Protein |
Escherichia coli (E. coli) |
2 |
PX-P6056-100UG |
Recombinant Monkeypox virus/MPXV M1R Protein |
Mammalian cells |
3 |
PX-P6057-100UG |
Recombinant Monkeypox virus/MPXV A29L Protein |
Mammalian cells |
4 |
PX-P6058-100UG |
Recombinant Monkeypox virus/MPXV D14L Protein |
Mammalian cells |
5 |
PX-P6059-100UG |
Recombinant Monkeypox virus/MPXV H3L Protein |
Mammalian cells |
6 |
PX-P6060-100UG |
Recombinant Monkeypox virus/MPXV A14L Protein |
Escherichia coli (E. coli) |
7 |
PX-P6061-100UG |
Recombinant Monkeypox virus/MPXV F3L Protein |
Escherichia coli (E. coli) |
8 |
PX-P6062-100UG |
Recombinant Monkeypox virus/MPXV HA/B2R Protein |
Mammalian cells |
9 |
PX-P6055-100UG |
Recombinant Monkeypox virus/MPXV E8L Protein |
Mammalian cells |
10 |
PX-P6011-100UG |
Recombinant Monkeypox virus/MPXV H3L Protein, N-His |
Escherichia coli (E. coli) |
11 |
PX-P6034-100UG |
Recombinant Monkeypox virus/MPXV A35R Protein |
Mammalian cells |
12 |
PX-P6033-100UG |
Recombinant Monkeypox virus/MPXV A33R Protein |
Escherichia coli (E. coli) |
13 |
PX-P6032-100UG |
Recombinant Monkeypox virus/MPXV L1R Protein |
Escherichia coli (E. coli) |
14 |
PX-P6031-100UG |
Recombinant Monkeypox virus/MPXV B6R/SL-159 Protein |
Mammalian cells |
15 |
PX-P6013-100UG |
Recombinant Monkeypox virus/MPXV A26L Protein, N-GST & C-His |
Escherichia coli (E. coli) |
16 |
PX-P6012-100UG |
Recombinant Monkeypox virus/MPXV C18L Protein, N-His |
Escherichia coli (E. coli) |
17 |
PX-P6010-100UG |
Recombinant Monkeypox virus/MPXV A44R Protein, N-GST & C-His |
Escherichia coli (E. coli) |
18 |
PX-P6009-100UG |
Recombinant Monkeypox virus/MPXV B2R/Hemagglutinin Protein, N-His |
Escherichia coli (E. coli) |
19 |
PX-P6008-100UG |
Recombinant Monkeypox virus/MPXV D13L Protein, N-His |
Escherichia coli (E. coli) |
20 |
PX-P6007-100UG |
Recombinant Monkeypox virus/MPXV C19L Protein, N-His |
Escherichia coli (E. coli) |
21 |
PX-P6006-100UG |
Recombinant Monkeypox virus/MPXV A36R Protein, N-His |
Escherichia coli (E. coli) |
22 |
PX-P6005-100UG |
Recombinant Monkeypox virus/MPXV B5R Protein, N-His |
Escherichia coli (E. coli) |
23 |
PX-P6004-100UG |
Recombinant Monkeypox virus/MPXV A33R Protein, N-His |
Escherichia coli (E. coli) |
24 |
PTX18825-100UG |
Monkeypox virus/MPXV A35R Monoclonal Antibody SAA0287 |
Mouse |
25 |
PTX18824-100UG |
Monkeypox virus/MPXV A29L Monoclonal Antibody SAA0286 |
Mouse |
26 |
PTX18822-100UG |
Monkeypox virus/MPXV M1R Monoclonal Antibody SAA0284 |
Mouse |
27 |
PTX18823-100UG |
Monkeypox virus/MPXV E8L Monoclonal Antibody SAA0285 |
Mouse |
28 |
PTX18821-100UG |
Monkeypox virus/MPXV M1R SAA0283 Monoclonal Antibody SAA0283 |
Mouse |
29 |
PTX18820-100UG |
Monkeypox virus/MPXV H3L Monoclonal Antibody SAA0282 |
Mouse |
Proteogenix의 고품질 CHO CELL 제품
[XtenCHOTM] High-quality reagents
|
• Higher yield – Up to 10x higher than other commercial systems
• Extended transient gene expression – 14+ days plasmid retention
• Time saving – Cell doubling time 23 hours / Cell recovery time after thawing 2 days
• Highest protein expression levels on the market – Record lead 904 mg/L of protein
• Optimal protein folding & post-translational modifications
|
|
|
Couldn't find your product of interest?
|
|
|
PROTEOGENIX - Official Distributor in South Korea " Morebio" 한국 독점 대리점 "모아바이오"
#101 Bio, #Antibody System, #Accegen, #Acro Biosystems, #AFG Scientific, #Bachem, #Biovision, #BioAssay Systems, #Bovogen, #Bioingentech, #Biosynth Carbosynth, #BMA, #Cusabio, #Creative Diagnostics, #CD Bioparticles, #Diaclone, #ECACC, #EastCoast Bio, #Elabscience, #eEnzyme, #GlycoNZ, #Golden West Diagnostics, #HyTest, #Lee Biosolutions, #Minerva Bioloabs, #Mybiosource, #Meridian Bioscience, #MD Biosciences, #Medix Biochemica, #Mediagnost, #Neuromics, #NIBSC,
#Nanoimmunotech, #Proteogenix, #Primer #Design, #Prospec, #Pel-Freez, #Signosis, #Salimetrics, #Virion Serion, #Vriongy, #DNA, #RNA, #PCR, #Antibody, #Elisa, #Kit, #Cell, #Cell Line, #Protein, #Nano Particle, #Immuno, #IVD, #Human, #Serum, #FBS,#Monkey, #Monkeypox, Corona, Covid, Virus, Sars, #Rekom Biotech, #GenomeMe, #Ichorbio, #Omicron, Biosimilars
ProteoGenix의 모든 제품들을 만나보세요!
|